Swiss Lab Buys Partek's Genomics Lab for Epigenetic, Neurobio Studies | GenomeWeb
NEW YORK (GenomeWeb News) — The Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland has bought Partek’s tiling and exon array data-handling software, Partek said yesterday.  
Partek said FMI’s Functional Genomics Lab will use its genomics suite software to analyze data from studies of epigenetics, growth control, and neurobiology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.